New C. diff test released

Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced.

“The Clarity toxin A/B assay offers a new approach to testing for C. diff and represents a significant and much-needed advance in infection control,” said Stephen Young, Professor Emeritus of Pathology at University of New Mexico, and Director of Research and Clinical Trials at TriCore Reference Laboratories.

The toxin A/B assay detects C. diff toxins at a high sensitivity, giving results in under 35 minutes.

“Currently available methods for the diagnosis of true C. difficile infection are complicated, only detect the organism, and/or lack in sensitivity or specificity, making it very difficult for hospitals to gain control of this very serious infection” said Guido Baechler, president and CEO at Singulex.